Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

News Industry News

Doctor's Best Introduces Two New Heart Health Supplements

August 11, 2015

News Industry News

First patient enrolled in Pivotal's POMEGA Phase IIa clinical trial with PVT-100

June 04, 2015

News Industry News

Amarin Reaffirms Its Mission to Improve Patient Care With Commitment to Completing REDUCE-IT Cardiovascular Outcomes Study

September 16, 2014

News Industry News

Boston Scientific Receives FDA Approval for REBEL™ Platinum Chromium Coronary Stent System

July 21, 2014

News Industry News

Amarin Announces Publication of Case Study Results Describing Reductions in Multiple Lipid Parameters for Individual Hyperlipidemic Patients Switched to Vascepa(R)

June 11, 2014

News Industry News

US FDA approves EPANOVA for the treatment of adults with severe hypertriglyceridaemia

May 06, 2014

News Industry News

Boston Scientific Receives CE Mark Approval for REBEL™ Platinum Chromium Coronary Stent System

March 12, 2014

News Industry News

Boston Scientific Receives FDA Approval for 32 MM and 38 MM Lengths for PROMUS Element™ Plus Platinum Chromium Stent System

June 04, 2012

News Industry News

Boston Scientific Supports New Clinical Trial to Evaluate Platinum Chromium Coronary Stents in Treating Heart Attack Patients

March 26, 2012

News Industry News

Boston Scientific Receives FDA Approval for PROMUS Element™ Plus Platinum Chromium Stent System

November 21, 2011

News Industry News

Boston Scientific Begins Clinical Trial Enrollment for OMEGA™ Platinum Chromium Stent System

October 05, 2011

News Industry News

Boston Scientific Announces European Approval and Launch of OMEGA™ Platinum Chromium Stent System

March 06, 2011

Advertisement

Doctor's Best Introduces Two New Heart Health Supplements

First patient enrolled in Pivotal's POMEGA Phase IIa clinical trial with PVT-100

Amarin Reaffirms Its Mission to Improve Patient Care With Commitment to Completing REDUCE-IT Cardiovascular Outcomes Study

Boston Scientific Receives FDA Approval for REBEL™ Platinum Chromium Coronary Stent System

Amarin Announces Publication of Case Study Results Describing Reductions in Multiple Lipid Parameters for Individual Hyperlipidemic Patients Switched to Vascepa(R)

US FDA approves EPANOVA for the treatment of adults with severe hypertriglyceridaemia

Boston Scientific Receives CE Mark Approval for REBEL™ Platinum Chromium Coronary Stent System

Boston Scientific Receives FDA Approval for 32 MM and 38 MM Lengths for PROMUS Element™ Plus Platinum Chromium Stent System

Boston Scientific Supports New Clinical Trial to Evaluate Platinum Chromium Coronary Stents in Treating Heart Attack Patients

Boston Scientific Receives FDA Approval for PROMUS Element™ Plus Platinum Chromium Stent System

Boston Scientific Begins Clinical Trial Enrollment for OMEGA™ Platinum Chromium Stent System

Boston Scientific Announces European Approval and Launch of OMEGA™ Platinum Chromium Stent System

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content